Drug Discovery Technology Alert. Anti-Telomerase Therapy for Drug-Resistant Mature or Stem Cancer Cells; Carbohydrate Mimetic Peptide as Effective Drug Delivery Vehicle; Ellipticine Compounds as Anti-Obesity Small Molecule Therapeutics
This issue profiles using an anti-telomerase therapy for drug-resistant mature or stem cancer cells, using carbohydrate mimetic peptide as an effective drug delivery vehicle, and using ellipticine compounds as anti-obesity small molecule therapeutics.
Click headings to expand and collapse
Published: 16 Dec 2011
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..